Literature DB >> 25807095

Systemic sclerosis: commonly asked questions by rheumatologists.

Amber Young1, Dinesh Khanna.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25807095      PMCID： PMC4809422          DOI： 10.1097/RHU.0000000000000232

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN： 1076-1608            Impact factor:   3.517


× No keyword cloud information.
  41 in total

Review 1.  Gastrointestinal complications: the most frequent internal complications of systemic sclerosis.

Authors:  A Forbes; I Marie
Journal:  Rheumatology (Oxford)       Date:  2009-06       Impact factor: 7.580

Review 2.  Gastrointestinal manifestations of scleroderma.

Authors:  S Rose; M A Young; J C Reynolds
Journal:  Gastroenterol Clin North Am       Date:  1998-09       Impact factor: 3.806

Review 3.  Old medications and new targeted therapies in systemic sclerosis.

Authors:  Vivek Nagaraja; Christopher P Denton; Dinesh Khanna
Journal:  Rheumatology (Oxford)       Date:  2014-07-26       Impact factor: 7.580

4.  Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies.

Authors:  M Kuwana; Y Okano; J Kaburaki; T Tojo; T A Medsger
Journal:  Arthritis Rheum       Date:  1994-06

5.  Long-term safety and effectiveness of tumour necrosis factor inhibitors in systemic sclerosis patients with inflammatory arthritis.

Authors:  Mohammed A Omair; Veerapong Phumethum; Sindhu R Johnson
Journal:  Clin Exp Rheumatol       Date:  2012-05-29       Impact factor: 4.473

6.  EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).

Authors:  O Kowal-Bielecka; R Landewé; J Avouac; S Chwiesko; I Miniati; L Czirjak; P Clements; C Denton; D Farge; K Fligelstone; I Földvari; D E Furst; U Müller-Ladner; J Seibold; R M Silver; K Takehara; B Garay Toth; A Tyndall; G Valentini; F van den Hoogen; F Wigley; F Zulian; Marco Matucci-Cerinic
Journal:  Ann Rheum Dis       Date:  2009-01-15       Impact factor: 19.103

Review 7.  Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma).

Authors:  H Sallam; T A McNearney; J D Z Chen
Journal:  Aliment Pharmacol Ther       Date:  2006-03-15       Impact factor: 8.171

8.  Prediction of pulmonary complications and long-term survival in systemic sclerosis.

Authors:  Svetlana I Nihtyanova; Benjamin E Schreiber; Voon H Ong; Daniel Rosenberg; Pia Moinzadeh; J Gerrard Coghlan; Athol U Wells; Christopher P Denton
Journal:  Arthritis Rheumatol       Date:  2014-06       Impact factor: 10.995

Review 9.  Gastrointestinal manifestations of systemic sclerosis.

Authors:  Robyn Domsic; Kenneth Fasanella; Klaus Bielefeldt
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

Review 10.  The development of systemic sclerosis classification criteria.

Authors:  Jennifer G Walker; Janet Pope; Murray Baron; Sharon Leclercq; Marie Hudson; Suzanne Taillefer; Steven M Edworthy; Oleg Nadashkevich; Marvin J Fritzler
Journal:  Clin Rheumatol       Date:  2007-02-07       Impact factor: 3.650
View more
  7 in total

1.  Hand Impairment in Systemic Sclerosis: Various Manifestations and Currently Available Treatment.

Authors:  Amber Young; Rajaie Namas; Carole Dodge; Dinesh Khanna
Journal:  Curr Treatm Opt Rheumatol       Date:  2016-07-19

Review 2.  Management of connective tissue diseases associated interstitial lung disease: a review of the published literature.

Authors:  Beth Wallace; Dharshan Vummidi; Dinesh Khanna
Journal:  Curr Opin Rheumatol       Date:  2016-05       Impact factor: 5.006

3.  Poor maternal and foetal outcomes in women with systemic sclerosis: an interview-based study at a tertiary centre.

Authors:  Rajat Kharbanda; R Naveen; Durga Prasanna Misra; Latika Gupta; Vikas Agarwal
Journal:  Rheumatol Int       Date:  2021-03-08       Impact factor: 2.631

Review 4.  Progress in understanding the diagnostic and pathogenic role of autoantibodies associated with systemic sclerosis.

Authors:  May Y Choi; Marvin J Fritzler
Journal:  Curr Opin Rheumatol       Date:  2016-11       Impact factor: 5.006

5.  Selective deletion of PPARβ/δ in fibroblasts causes dermal fibrosis by attenuated LRG1 expression.

Authors:  Ming Keat Sng; Jeremy Soon Kiat Chan; Ziqiang Teo; Terri Phua; Eddie Han Pin Tan; Jonathan Wei Kiat Wee; Nikki Jun Ning Koh; Chek Kun Tan; Jia Peng Chen; Mintu Pal; Benny Meng Kiat Tong; Ya Lin Tnay; Xuan Rui Ng; Pengcheng Zhu; Shunsuke Chiba; Xiaomeng Wang; Walter Wahli; Nguan Soon Tan
Journal:  Cell Discov       Date:  2018-04-03       Impact factor: 10.849

6.  Metabolic Pattern of Systemic Sclerosis: Association of Changes in Plasma Concentrations of Amino Acid-Related Compounds With Disease Presentation.

Authors:  Zaneta Smolenska; Magdalena Zabielska-Kaczorowska; Anna Wojteczek; Barbara Kutryb-Zajac; Zbigniew Zdrojewski
Journal:  Front Mol Biosci       Date:  2020-10-15

7.  Things left unsaid: important topics that are not discussed between patients with systemic sclerosis, their carers and their healthcare professionals-a discourse analysis.

Authors:  Christopher P Denton; Bee Laird; Lizette Moros; Jose Luis Luna Flores
Journal:  Clin Rheumatol       Date:  2020-09-11       Impact factor: 2.980
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.